Method Sign up free

Borrower record · Q2 2026

Lexicon Pharmaceuticals

As filed by Hercules Capital, Inc. · period end 30 June 2026No sector — one filer, nothing to corroborate

Hercules Capital, Inc. is the only BDC lending to Lexicon Pharmaceuticals: $39.9m across two positions at Q2 2026, marked at 100.7 cents.

Filed fair value
$39.9m
2 funded positions
Aggregate mark
100.7c
cost filed on all 2 positions
Filed spread
310bp
over Prime, one floating tranche
Maturities to
2030
one date, 1 May 2030
Periods on record
1
first seen Q2 2026

How this total is counted

Capital structure

First-Lien Senior Secured1 position
$39.1m
98.2%
Equity/Other1 position
$725k
1.8%

All 2 funded positions carry a filed seniority.

Rate structure

Floating, on the one position whose interest type a filer disclosed.

1 of 2 funded positions carries no filed interest type.

Maturity profile

1 of 2 funded positions dated
2030
$39.1m

3.8 years to maturity, weighted by fair value across the 1 dated position.

Credit flags

The filer reports no position on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Tell me when this changes.

One lender reports Lexicon Pharmaceuticals today. We will email you when a second one does, when Hercules Capital, Inc.'s mark moves, or when the position leaves the schedule.

Every filing behind this page

1 filer · Q2 2026
FilerCIKFormPeriodFiledAccession
Hercules Capital, Inc. (HTGC)000128078410-Q2026-06-302026-07-300001280784-26-000042

Related borrowers

Same lender